Clinical trials
Observational Neurofibroma, Plexiform trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
14 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2001 | 1 |
| 2004 | 1 |
| 2008 | 1 |
| 2013 | 1 |
| 2015 | 1 |
| 2016 | 1 |
| 2017 | 1 |
| 2019 | 2 |
| 2022 | 1 |
| 2023 | 1 |
| 2024 | 3 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 4 |
| Recruiting | 3 |
| Enrolling by invitation | 2 |
| Active, not recruiting | 2 |
| Terminated | 1 |
| Unknown status | 1 |
| Withdrawn | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| National Cancer Institute (NCI) | 6 |
| AstraZeneca | 2 |
| Alexion Pharmaceuticals, Inc. | 1 |
| Ann & Robert H Lurie Children's Hospital of Chicago | 1 |
| Corewell Health West | 1 |
| David Miller | 1 |
| Shanghai Ninth People's Hospital Affiliated to Shanghai Jiao Tong University | 1 |
| UNC Lineberger Comprehensive Cancer Center | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Neurofibroma, Plexiform | 14 |
| Neurofibromatosis 1 | 9 |
| Neurofibroma | 3 |
| Neurofibrosarcoma | 3 |
| Neoplasms | 2 |
| Optic Nerve Glioma | 2 |
| Adenomatous Polyposis Coli | 1 |
| Brain Neoplasms | 1 |
| Myelodysplastic Syndromes | 1 |
| Neoplasms, Germ Cell and Embryonal | 1 |
Trials
Showing 51 to 14 of 14. Each trial links to its page on Pharma Observatory.
No trials match these filters.
Try a different keyword, or clear a filter.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.